4th Annual Medical Device Cybersecurity Risk Mitigation Conference

July 2019 | Arlington, VA
Request Invitation

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

Connected medical device products and technologies continue to play a crucial role in the automation and streamlining of healthcare delivery, but also require a comprehensive and immersive level of cybersecurity risk mitigation to ensure products remain free from intrusion. Collaboration across the industry, from medical device manufacturers, government agency regulators and healthcare delivery organizations directly will ensure a balanced and thoughtful approach to risk mitigation, protecting devices from potential intrusion and eliminating vulnerabilities.

Topics to Be Addressed:

  • Resolving cybersecurity vulnerabilities in legacy medical products
  • Cybersecurity assessments within FDA & MDSAP frameworks
  • Full product lifecycle considerations for device cybersecurity
  • Balancing risks & responsibilities between manufacturers & HDOs
  • Mitigating risks, vulnerabilities and potential intrusions

Program Highlights:

  • Multiple HDO perspectives on cybersecurity risk mitigation
  • Government agency perspectives: FDA, NIH and more
  • Medical device industry experts in knowledge share sessions

Audience

75 Attendees

All attendees come directly from medical device companies

Distinguished Presenters

Speaker recruitment in process

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This